We screened three different osteosarcoma cell lines and the myelogenous leukemia cell line K562 for the expression of CD301 ligands by staining with a recombinant, soluble CD301 analyzed in flow cytometry (Figure 2C). The gene discussed is CLEC10A; the disease is osteosarcoma.